Evidence map›Paper›PMID 17499555›Full record

ArticleThe journal of pain2007

Substance use disorders in a primary care sample receiving daily opioid therapy.

Michael F Fleming, Stacey L Balousek, Cynthia L Klessig, Marlon P Mundt, David D Brown

Abstract read
In one paragraph

Article in The journal of pain, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Guideline
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael F FlemingDepartment of Family Medicine, University of Wisconsin, Madison, Wisconsin 53715, USA. mfleming@fammed.wisc.edu
Stacey L Balousek
Cynthia L Klessig
Marlon P Mundt
David D Brown

Funding

NIH NRSA Institutional Research Training Grant (T32)T32AA014845 · NIAAA · UNIVERSITY OF WISCONSIN-MADISON · PI FLEMING, MICHAEL F. · 2004 to 2008
$827k
Opioid Addiction in Primary Care Chronic Pain PatientsR01DA013686 · NIDA · UNIVERSITY OF WISCONSIN MADISON · PI FLEMING, MICHAEL F · 2001 to 2002
$728k
NIAAA NIH HHS T32 AA014845NIDA NIH HHS R01 DA013686
6 · The paper itself

Abstract

unlabelledThe primary goal of this paper was to present a comprehensive picture of substance use disorders in a sample of patients receiving opioid therapy from their primary care physician. A second goal was to determine the relation of positive urine screens and aberrant drug behaviors to opioid use disorders. The study recruited 801 adults receiving daily opioid therapy from the primary care practices of 235 family physicians and internists in 6 health care systems in Wisconsin. The 6 most common pain diagnoses were degenerative arthritis, low back pain, migraine headaches, neuropathy, and fibromyalgia. The point prevalence of current (DSM-IV criteria in the past 30 days) substance abuse and/or dependence was 9.7% (n=78) and 3.8% (30) for an opioid use disorder. A logistic regression model found that current substance use disorders were associated with age between 18 and 30 (OR=6.17: 1.99 to 19.12), severity of lifetime psychiatric disorders (OR=6.17; 1.99 to 19.12), a positive toxicology test for cocaine (OR=5.92; 2.60 to 13.50) or marijuana (OR=3.52; 1.85 to 6.73), and 4 aberrant drug behaviors (OR=11.48; 6.13 to 21.48). The final model for opioid use disorders was limited to aberrant behaviors (OR=48.27; 13.63 to 171.04) as the other variables dropped out of the model. PERSPECTIVE: This study found that the frequency of opioid use disorders was 4 times higher in patients receiving opioid therapy compared with general population samples (3.8% vs 0.9%). The study also provides quantitative data linking aberrant drug behaviors to opioid use disorders.

Indexed as

AdolescentAdultAgedAged, 80 and overAnalgesics, OpioidCausalityChronic DiseaseCocaine-Related DisordersComorbidityDrug Administration ScheduleHumansIntractable PainLogistic ModelsMarijuana AbuseMass ScreeningMiddle AgedAnalgesics, Opioid

Identifiers

PMID17499555
PMCPMC1959336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.